Molecular and serologic markers of acute dengue infection in naive and flavivirus-vaccinated travelers
- Cristina Domingo,
- Fernando de Ory,
- Juan Carlos Sanz,
- Noelia Reyes,
- Joaquim Gascón,
- Ole Wichmann
- Instituto de Salud Carlos III,
- Regional Public Health Laboratory of the Madrid County,
- Hospital Clinic Barcelona,
- Charité Universitätsmedizin Berlin,
- Carlos III Hospital,
- University of Munich
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 42-48 (7 pages)Journal (Volume, Issue Number)
Diagnostic Microbiology and Infectious Disease (Volume 65, Issue 1)Publication milestones
- Published - 09/2009
Publication status
ISSN
0732-8893Publication IDs
- Scopus: 68349104964
- PubMed: 19679234
Abstract
A total of 520 European travelers with suspected dengue fever were examined, and acute dengue virus infection was confirmed in 127 of them. Molecular and serological tests for dengue diagnosis, according to their usefulness in the different stages of the disease, were performed. The accuracy of the IgM/IgG ratio and the IgG avidity index was confirmed during the early phase of the illness to discriminate the serologic status (primary versus secondary immune response) of patients who were either naive or previously vaccinated against other flaviviruses. Virologic markers of secondary infection were detected in 11.8% of nonvaccinated infected patients and in 92.6% of yellow fever vaccinated patients. The proper use of these simple methodologies could help in the identification of patients affected with secondary infection, who may be at a higher risk of developing a hemorrhagic disorder.
Funding Details
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
